Genomics: Funding, Investors & Team (Sep 2026)
The goal of Genomics plc is to take the lead in revolutionizing healthcare through genomics. They aim to utilize complex analyses of large sets of combined genetic and observable data to gain insights into human biology and uncover the blueprint of human genetics. With their expertise and experience, they intend to pave the way in this field, unlocking the full potential of genomics and establishing the benchmarks for organizations and patients to utilize genomic data effectively.
Genomics has raised $44.5M across 1 funding round on record, the most recent a Series C of $44.5M announced in Jan 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genomics Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Genomics Funding Rounds
Genomics Founders and Leadership Team
No contact details are on record for this team yet.
Genomics Funding Compared to Other Biotechnology Startups
Genomics' latest round of $44.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genomics in Biotechnology and Oxford
Companies Similar to Genomics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Genomics Funding FAQs
What does Genomics do?
The goal of Genomics plc is to take the lead in revolutionizing healthcare through genomics. They aim to utilize complex analyses of large sets of combined genetic and observable data to gain insights into human biology and uncover the blueprint of human genetics. With their expertise and experience, they intend to pave the way in this field, unlocking the full potential of genomics and establishing the benchmarks for organizations and patients to utilize genomic data effectively.
How much funding has Genomics raised?
Genomics has raised $44.5M across 1 round on record. The most recent is a Series C of $44.5M announced in Jan 2024.
When did Genomics last raise funding?
Genomics' most recent funding round on record is a Series C of $44.5M, announced in Jan 2024.
Who founded Genomics?
FundedIQ lists Peter Donnelly (Founder) at Genomics.
Where is Genomics headquartered?
Genomics is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Genomics have?
Genomics is in the 101-250 employee band.
How does Genomics' funding compare to other Biotechnology startups?
Genomics' latest round of $44.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.